Impact of salvage treatment modalities in patients with positive FDG-PET/CT after R-CHOP chemotherapy for aggressive B-cell non-Hodgkin lymphoma

Author:

Chin Vicky1ORCID,Fulham Michael23,Hertzberg Mark45,Jackson Michael15,Lindeman Robert456,Brighton Timothy45,Kidson-Gerber Giselle45,Wegner Eva A7,Cheung Carol4,MacCallum Susan45,Williams Janet15,Thompson Stephen R15

Affiliation:

1. Department of Radiation Oncology; Prince of Wales Hospital; Sydney New South Wales Australia

2. Department of Molecular Imaging (PET and Nuclear Medicine); Royal Prince Alfred Hospital; Sydney New South Wales Australia

3. Sydney Medical School; University of Sydney; Sydney New South Wales Australia

4. Department of Haematology; Prince of Wales Hospital; Sydney New South Wales Australia

5. University of New South Wales; Sydney New South Wales Australia

6. NSW Health Pathology; Sydney New South Wales Australia

7. Department of Nuclear Medicine and PET; Prince of Wales Hospital; Sydney New South Wales Australia

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Hematological Diseases Mimic Inflammation;PET/CT for Inflammatory Diseases;2019-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3